Recent Updates
Recently added Catalysts
RLAY Positive Sentiment

Relay Therapeutics to Host New Program and Platform Event on June 6, 2024

Monday, May 13, 2024 BiopharmaWatch Research 1 min read
Add on Google
Key Takeaway: Relay Therapeutics will host a New Program and Platform event on June 6, 2024, to showcase new initiatives from its pre-clinical pipeline. This hybrid event will allow for limited in-person attendance and a virtual option for wider access. Participants can register to view the live presentation or access an archived replay for a limited time following the event.
Price reaction · baseline $6.42 (2024-05-10 close) · clean, no other RLAY news in the window
day 0 close
0%

Market Sentiment Analysis

POSITIVE FACTORS

  • Relay Therapeutics is disclosing new programs from its pre-clinical pipeline.
  • The event facilitates connection with the investment community and expands outreach through a webcast.
  • The use of the Dynamo™ platform indicates innovative technologies leading to novel discoveries.

BiopharmaWatch Analysis

From our catalyst data and publicly available data · not financial advice
Best trade, last catalyst
+284%
120-day peak, hindsight
Typical move
11.8%
average across 6 past catalysts
Cash runway
~50 mo
Minimal dilution risk
Lead asset
RLY-8161
Phase 1 · Advanced NRAS-Mutant Melanoma

Full Press Release Details

CAMBRIDGE, Mass., May 13, 2024 (GLOBE NEWSWIRE) -- Relay Therapeutics, Inc. (Nasdaq: RLAY), a clinical-stage precision medicine company transforming the drug discovery process by combining leading-edge computational and experimental technologies, today announced that the company will host a New Program and Platform event on Thursday, June 6, 2024 from 8:00 to 10:00 a.m. ET. During the event, the company will disclose new programs from its existing pre-clinical pipeline and review how the Dynamo™ platform led to these novel discoveries.
The event will be a hybrid format, with limited in-person attendance available to members of the investment community, and a simultaneous webcast will be available for all interested parties who wish to join virtually.
The live presentation can be accessed through Relay Therapeutics’ website under “Events” in the News & Events section through the following link: https://ir.relaytx.com/news-events/events-presentations. An archived replay of the webcast will be available for up to 30 days following the event. To participate in the live webcast, please register for the event here. It is recommended that participants register at least 15 minutes in advance of the event.
About Relay Therapeutics

Frequently Asked Questions

When will Relay Therapeutics' event take place?

The event is scheduled for June 6, 2024, from 8:00 to 10:00 a.m. ET.

What will be discussed at the event?

The event will reveal new programs from the pre-clinical pipeline and discuss the Dynamo™ platform.

How can I attend the Relay Therapeutics event?

Attendance is hybrid; register for in-person or join the livestream via their website.

Is the event available for virtual attendance?

Yes, there will be a simultaneous webcast for virtual attendees.

How long will the webcast replay be available?

The archived replay will be accessible for up to 30 days after the event.

ShareAdd on Google
Tags: RLAY Viatris Investor Conferences Healthcare Relay Therapeutics drug discovery Dynamo platform clinical-stage
Last updated: May 13, 2024

Biotech snapshot

Cash runway
$911M liquidity · $18M/mo burn
~50 mo
Minimal dilution risk
Lead asset
RLY-8161Phase 1
Advanced NRAS-Mutant Melanoma →

Catalyst track record

+284%
best trade around RLAY's most recent catalyst

Peak hindsight return over a 120-day window, across 6 tracked FDA/PDUFA catalysts for RLAY.

See every catalyst's timing & PoA →